Cyndi Qixin He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cyndi Qixin He has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Kendall. N. Houk
Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, USA
3 shared publications Lushi Tan
Merck & Co., Inc.
3 shared publications- Marion Heidi Emmert
Process Research and Development, MRL, Merck & Co., Inc., 126 E Lincoln Ave, Rahway, New Jersey 07065, United States
3 shared publications - Shane William Krska
Discovery Chemistry, Merck & Co., Inc
3 shared publications - Shannon S. Stahl
University of Wisconsin−Madison 1101 University Avenue
3 shared publications - Stephanie Felten
Process Research and Development, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States
3 shared publications
Latest Publications
- 19 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (42) , 45322-45329
Asymmetric Copper-Catalyzed Conjugate Addition with Trimethylboroxine Enables Direct Synthesis of Frespaciguat
Herein we disclose a concise synthesis of inhaled soluble guanylate cyclase (isGC) stimulator Frespaciguat (MK-5475) that relies exclusively on complexity-increasing transformations from commodity chemicals. Key transformations include a solvent-free photochemical reaction that converts two gaseous reactants into a liquid product in high yield; a direct ester-to-amidine conversion using HMDS, water, and triflic acid; and a rare example of enantioselective methylation via copper-catalyzed asymmetric conjugate addition (ACA) to install a quaternary center using trimethylboroxine as a nucleophile. Given the general challenge of asymmetric methyl installation, we further demonstrate the utility of this methodology beyond the present setting and suggest its strategic value in synthetic planning where nonracemic, quaternary methyl-containing stereocenters are required.
- 19 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (42) , 45322-45329
Asymmetric Copper-Catalyzed Conjugate Addition with Trimethylboroxine Enables Direct Synthesis of Frespaciguat
Herein we disclose a concise synthesis of inhaled soluble guanylate cyclase (isGC) stimulator Frespaciguat (MK-5475) that relies exclusively on complexity-increasing transformations from commodity chemicals. Key transformations include a solvent-free photochemical reaction that converts two gaseous reactants into a liquid product in high yield; a direct ester-to-amidine conversion using HMDS, water, and triflic acid; and a rare example of enantioselective methylation via copper-catalyzed asymmetric conjugate addition (ACA) to install a quaternary center using trimethylboroxine as a nucleophile. Given the general challenge of asymmetric methyl installation, we further demonstrate the utility of this methodology beyond the present setting and suggest its strategic value in synthetic planning where nonracemic, quaternary methyl-containing stereocenters are required.
- 19 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (35) , 11053-11057
Stereoselective Synthesis of MK-8527 Enabled by a Dynamic Kinetic Resolution Mitsunobu Glycosylation
A practical and asymmetric synthesis of potent anti-HIV nucleoside MK-8527 is described. The key discoveries are a novel stereoselective dynamic kinetic resolution (DKR) Mitsunobu glycosylation and selective amination of the resulting 2,6-dichloro nucleoside. The new route was successfully demonstrated on the kilogram scale and provided isolated MK-8527 with more than 99% HPLC purity through crystallization.
- 19 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (35) , 11053-11057
Stereoselective Synthesis of MK-8527 Enabled by a Dynamic Kinetic Resolution Mitsunobu Glycosylation
A practical and asymmetric synthesis of potent anti-HIV nucleoside MK-8527 is described. The key discoveries are a novel stereoselective dynamic kinetic resolution (DKR) Mitsunobu glycosylation and selective amination of the resulting 2,6-dichloro nucleoside. The new route was successfully demonstrated on the kilogram scale and provided isolated MK-8527 with more than 99% HPLC purity through crystallization.
- Top Cited Papers
- 14 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6799) , eaed6880
A unified platform for nucleoside analog synthesis
Nucleoside analogs (NAs) are essential as antiviral and anticancer therapies. Despite decades of focused medicinal chemistry efforts, their related chemical space remains underexplored, mainly owing to their lengthy, single-molecule–oriented syntheses that lack the flexibility required to generate NA libraries. Here we report a flexible, robust, and efficient platform for the high-throughput synthesis of NAs using a photoredox coupling strategy. This approach produces both carbon- and nitrogen-linked NAs and unifies the synthesis of several disparate NA classes, including 4′-thio, 4′-imino, and ProTides, all from a simple, scalable intermediate. Using this platform, we demonstrate the production of a diverse NA library and identify several hit compounds with anti–HIV-1 activity. We expect that this newly developed approach to NAs will inspire and support drug discovery efforts in this area.
- 14 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6799) , eaed6880
Top Cited PapersA unified platform for nucleoside analog synthesis
Nucleoside analogs (NAs) are essential as antiviral and anticancer therapies. Despite decades of focused medicinal chemistry efforts, their related chemical space remains underexplored, mainly owing to their lengthy, single-molecule–oriented syntheses that lack the flexibility required to generate NA libraries. Here we report a flexible, robust, and efficient platform for the high-throughput synthesis of NAs using a photoredox coupling strategy. This approach produces both carbon- and nitrogen-linked NAs and unifies the synthesis of several disparate NA classes, including 4′-thio, 4′-imino, and ProTides, all from a simple, scalable intermediate. Using this platform, we demonstrate the production of a diverse NA library and identify several hit compounds with anti–HIV-1 activity. We expect that this newly developed approach to NAs will inspire and support drug discovery efforts in this area.
- 13 January 2026
- Published by American Chemical Society (ACS) in Organic Letters
Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)
MK-1084 is a potent KRAS G12 inhibitor characterized by a complex macrocyclic ring system incorporating two atropisomeric axes from a restricted rotation around both C-C and N-C bonds. Herein, we report an efficient synthetic approach to manufacture MK-1084 to enable clinical trials. By leveraging the in-depth understanding of the inherent properties of axial chirality, we discovered and developed a one-pot crystallization-induced diastereomer transformation (CIDT)/carbonylation process to establish the unique and challenging macrocyclic core with double axial chiral centers from a racemic advanced precursor and readily available raw materials.
- 13 January 2026
- Published by American Chemical Society (ACS) in Organic Letters
Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)
MK-1084 is a potent KRAS G12 inhibitor characterized by a complex macrocyclic ring system incorporating two atropisomeric axes from a restricted rotation around both C-C and N-C bonds. Herein, we report an efficient synthetic approach to manufacture MK-1084 to enable clinical trials. By leveraging the in-depth understanding of the inherent properties of axial chirality, we discovered and developed a one-pot crystallization-induced diastereomer transformation (CIDT)/carbonylation process to establish the unique and challenging macrocyclic core with double axial chiral centers from a racemic advanced precursor and readily available raw materials.
- 11 February 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (7) , 2613-2625
C–H Aminoalkylation of 5-Membered Heterocycles: Influence of Descriptors, Data Set Size, and Data Quality on the Predictiveness of Machine Learning Models and Expansion of the Substrate Space Beyond 1,3-Azoles
We report a general C-H aminoalkylation of 5-membered heterocycles through a combined machine learning/experimental workflow. Our work describes previously unknown C-H functionalization reactivity and creates a predictive machine learning (ML) model through iterative refinement over 6 rounds of active learning. The initial model established with 1,3-azoles predicts the reactivities of N-aryl indazoles, 1,2,4-triazolopyrazines, 1,2,3-thiadiazoles, and 1,3,4-oxadiazoles, while other substrate classes (e.g., pyrazoles and 1,2,4-triazoles) are not predicted well. The final model includes the reactivities of additional heterocyclic scaffolds in the training data, which results in high predictive accuracy across all of the tested cores. The high prediction performance is shown both within the training set via cross-validation (CV R2 = 0.81) and when predicting unseen substrates of diverse molecular weight and structure (Test R2 = 0.95). The concept of feature engineering is discussed, and we benchmark mechanistically related DFT-based features that are more time-intensive and laborious in comparison with molecular descriptors and fingerprints. Importantly, this work establishes novel reactivity for heterocycles for which C-H functionalization methods are underdeveloped. Since such heterocycles are key motifs in drug discovery and development, we expect this work to be of significant use to the synthetic and synthesis-oriented ML communities.
- 11 February 2025
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 90 (7) , 2613-2625
C–H Aminoalkylation of 5-Membered Heterocycles: Influence of Descriptors, Data Set Size, and Data Quality on the Predictiveness of Machine Learning Models and Expansion of the Substrate Space Beyond 1,3-Azoles
We report a general C-H aminoalkylation of 5-membered heterocycles through a combined machine learning/experimental workflow. Our work describes previously unknown C-H functionalization reactivity and creates a predictive machine learning (ML) model through iterative refinement over 6 rounds of active learning. The initial model established with 1,3-azoles predicts the reactivities of N-aryl indazoles, 1,2,4-triazolopyrazines, 1,2,3-thiadiazoles, and 1,3,4-oxadiazoles, while other substrate classes (e.g., pyrazoles and 1,2,4-triazoles) are not predicted well. The final model includes the reactivities of additional heterocyclic scaffolds in the training data, which results in high predictive accuracy across all of the tested cores. The high prediction performance is shown both within the training set via cross-validation (CV R2 = 0.81) and when predicting unseen substrates of diverse molecular weight and structure (Test R2 = 0.95). The concept of feature engineering is discussed, and we benchmark mechanistically related DFT-based features that are more time-intensive and laborious in comparison with molecular descriptors and fingerprints. Importantly, this work establishes novel reactivity for heterocycles for which C-H functionalization methods are underdeveloped. Since such heterocycles are key motifs in drug discovery and development, we expect this work to be of significant use to the synthetic and synthesis-oriented ML communities.
- 23 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (1) , 92-99
Impurity Control Strategy of TMS-Triol in the Manufacture Development of Islatravir
- 23 December 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (1) , 92-99
Impurity Control Strategy of TMS-Triol in the Manufacture Development of Islatravir
- 29 April 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (9) , 1515-1522
Persistent organonickel complexes as general platforms for Csp2–Csp3 coupling reactions
The importance of constructing Csp2–Csp3 bonds has motivated the development of electrochemical, photochemical and thermal activation methods to reductively couple abundant aryl and alkyl electrophiles. However, these methodologies are limited to couplings of very specific substrate classes and require specialized sets of catalysts and reaction set-ups. Here we show a consolidation of these myriad strategies into a single set of conditions that enable reliable alkyl–aryl couplings, including those that were previously unknown. These reactions rely on the discovery of unusually persistent organonickel complexes that serve as stoichiometric platforms for C(sp2)–C(sp3) coupling. Aryl, heteroaryl or vinyl complexes of Ni can be inexpensively prepared on a multigram scale by mild electroreduction from the corresponding C(sp2) electrophile. Organonickel complexes can be isolated and stored or telescoped directly to reliably diversify drug-like molecules. Finally, the procedure was miniaturized to micromole scales by integrating soluble battery chemistries as redox initiators, enabling a high-throughput exploration of substrate diversity.
- 29 April 2024
- Published by Springer Nature in Nature Chemistry
- Vol. 16 (9) , 1515-1522
Persistent organonickel complexes as general platforms for Csp2–Csp3 coupling reactions
The importance of constructing Csp2–Csp3 bonds has motivated the development of electrochemical, photochemical and thermal activation methods to reductively couple abundant aryl and alkyl electrophiles. However, these methodologies are limited to couplings of very specific substrate classes and require specialized sets of catalysts and reaction set-ups. Here we show a consolidation of these myriad strategies into a single set of conditions that enable reliable alkyl–aryl couplings, including those that were previously unknown. These reactions rely on the discovery of unusually persistent organonickel complexes that serve as stoichiometric platforms for C(sp2)–C(sp3) coupling. Aryl, heteroaryl or vinyl complexes of Ni can be inexpensively prepared on a multigram scale by mild electroreduction from the corresponding C(sp2) electrophile. Organonickel complexes can be isolated and stored or telescoped directly to reliably diversify drug-like molecules. Finally, the procedure was miniaturized to micromole scales by integrating soluble battery chemistries as redox initiators, enabling a high-throughput exploration of substrate diversity.
- 19 January 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (3) , 1438-1445
Broad Survey of Selectivity in the Heterogeneous Hydrogenation of Heterocycles
A broad survey of heterogeneous hydrogenation catalysts has been conducted for the reduction of heterocycles commonly found in pharmaceuticals. The comparative reactivity of these substrates is reported as a function of catalyst, temperature, and hydrogen pressure. This analysis provided several catalysts with complementary reactivity between substrates. We then explored a series of bisheterocyclic substrates that provided an intramolecular competition of heterocycle hydrogenation reactivity. In several cases, complete selectivity could be achieved for reduction of one heterocycle and isolated yields are reported. A general trend in reactivity is inferred in which quinoline is the most reactive, followed by pyrazine, then pyrrole and with pyridine being the least reactive.
- 19 January 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (3) , 1438-1445
Broad Survey of Selectivity in the Heterogeneous Hydrogenation of Heterocycles
A broad survey of heterogeneous hydrogenation catalysts has been conducted for the reduction of heterocycles commonly found in pharmaceuticals. The comparative reactivity of these substrates is reported as a function of catalyst, temperature, and hydrogen pressure. This analysis provided several catalysts with complementary reactivity between substrates. We then explored a series of bisheterocyclic substrates that provided an intramolecular competition of heterocycle hydrogenation reactivity. In several cases, complete selectivity could be achieved for reduction of one heterocycle and isolated yields are reported. A general trend in reactivity is inferred in which quinoline is the most reactive, followed by pyrazine, then pyrrole and with pyridine being the least reactive.
- Open Access
- 31 July 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Persistent Organonickel Complexes as General Platforms for Csp2-Csp3 Coupling Reactions
Coupling reactions between aryl electrophiles and alkyl/perfluoroalkyl precursors have inspired elegant methodologies that leverage electrochemical, photochemical, or thermal activation modalities. This work consolidates these myriad strategies to a single set of conditions and enables previously unknown alkyl-aryl couplings. These reactions rely on the discovery of unusually persistent organonickel complexes that serve as stoichiometric platforms for C(sp2)-C(sp3) coupling. Aryl, heteroaryl, or vinyl complexes of Ni can be inexpensively prepared on multigram scale by mild electroreduction from the corresponding C(sp2) electrophile. Organonickel complexes can be isolated and stored or telescoped directly to reliably diversify drug-like molecules. Finally, the procedure was miniaturized to µL scales by integrating soluble battery chemistries as redox initiators, which enabled a high-throughput exploration of substrate diversity.
- 31 July 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPersistent Organonickel Complexes as General Platforms for Csp2-Csp3 Coupling Reactions
Coupling reactions between aryl electrophiles and alkyl/perfluoroalkyl precursors have inspired elegant methodologies that leverage electrochemical, photochemical, or thermal activation modalities. This work consolidates these myriad strategies to a single set of conditions and enables previously unknown alkyl-aryl couplings. These reactions rely on the discovery of unusually persistent organonickel complexes that serve as stoichiometric platforms for C(sp2)-C(sp3) coupling. Aryl, heteroaryl, or vinyl complexes of Ni can be inexpensively prepared on multigram scale by mild electroreduction from the corresponding C(sp2) electrophile. Organonickel complexes can be isolated and stored or telescoped directly to reliably diversify drug-like molecules. Finally, the procedure was miniaturized to µL scales by integrating soluble battery chemistries as redox initiators, which enabled a high-throughput exploration of substrate diversity.
- 1 June 2023
- Published by Springer Nature in Nature Synthesis
- Vol. 2 (10) , 998-1008
Accessing three-dimensional molecular diversity through benzylic C–H cross-coupling
Pharmaceutical discovery efforts rely on robust synthetic methods that rapidly access diverse molecules. Cross-coupling reactions are the most widely used reactions, but these methods typically form bonds with C(sp2)-hybridized atoms and lead to a prevalence of ‘flat’ molecules with suboptimal physicochemical and topological properties. Benzylic C(sp3)–H cross-coupling offers an appealing strategy to address this limitation, as emerging methods exhibit synthetic versatility that rivals conventional cross-coupling to access drug-like products. Here we use a virtual library of benzylic ethers and ureas derived from benzylic C–H cross-coupling to test the widely held view that coupling at C(sp3)-hybridized centres affords products with improved three-dimensionality. The results show that the conformational rigidity of the benzylic scaffold strongly influences the product dimensionality. These concepts are validated through an informatics-guided synthesis and high-throughput experimentation to prepare three-dimensional products that are broadly distributed across drug-like chemical space.
- 1 June 2023
- Published by Springer Nature in Nature Synthesis
- Vol. 2 (10) , 998-1008
Accessing three-dimensional molecular diversity through benzylic C–H cross-coupling
Pharmaceutical discovery efforts rely on robust synthetic methods that rapidly access diverse molecules. Cross-coupling reactions are the most widely used reactions, but these methods typically form bonds with C(sp2)-hybridized atoms and lead to a prevalence of ‘flat’ molecules with suboptimal physicochemical and topological properties. Benzylic C(sp3)–H cross-coupling offers an appealing strategy to address this limitation, as emerging methods exhibit synthetic versatility that rivals conventional cross-coupling to access drug-like products. Here we use a virtual library of benzylic ethers and ureas derived from benzylic C–H cross-coupling to test the widely held view that coupling at C(sp3)-hybridized centres affords products with improved three-dimensionality. The results show that the conformational rigidity of the benzylic scaffold strongly influences the product dimensionality. These concepts are validated through an informatics-guided synthesis and high-throughput experimentation to prepare three-dimensional products that are broadly distributed across drug-like chemical space.